Developments IBM Watson Health selects iBio to support COVID-19 vaccine candidates IBM Watson Health selected iBio (NYSE American:IBIO) to receive 18 months use of the IBM clinical development (ICD) solution at no cost. IBM Watson Health recently began offering its clinical development solution to... June 24, 2020